Literature DB >> 32163150

Disentangling the Relationships Between the Renin-Angiotensin-Aldosterone System, Calcium Physiology, and Risk for Kidney Stones.

Omar Bayomy1, Sarah Zaheer2, Jonathan S Williams1, Gary Curhan3, Anand Vaidya1.   

Abstract

CONTEXT: Complex relationships between aldosterone and calcium homeostasis have been proposed.
OBJECTIVE: To disentangle the influence of aldosterone and intravascular volume on calcium physiology.
DESIGN: Patient-oriented and epidemiology studies.
SETTING: Clinical research center and nationwide cohorts. PARTICIPANTS/
INTERVENTIONS: Patient-oriented study (n = 18): Participants were evaluated after completing a sodium-restricted (RES) diet to contract intravascular volume and after a liberalized-sodium (LIB) diet to expand intravascular volume. Cross-sectional studies (n = 3755): the association between 24h urinary sodium and calcium excretion and risk for kidney stones was assessed.
RESULTS: Patient-oriented study: compared to a RES-diet, a LIB-diet suppressed renin activity (LIB: 0.3 [0.1, 0.4] vs. RES: 3.1 [1.7, 5.3] ng/mL/h; P < 0.001) and plasma aldosterone (LIB: 2.0 [2.0, 2.7] vs. RES: 20.0 [16.1, 31.0] vs. ng/dL; P < 0.001), but increased calciuria (LIB: 238.4 ± 112.3 vs. RES: 112.9 ± 60.8 mg/24hr; P < 0.0001) and decreased serum calcium (LIB: 8.9 ± 0.3 vs. RES: 9.8 ± 0.4 mg/dL; P < 0.0001). Epidemiology study: mean urinary calcium excretion was higher with greater urinary sodium excretion. Compared to a urinary sodium excretion of < 120 mEq/day, a urinary sodium excretion of ≥220 mEq/day was associated with a higher risk for having kidney stones in women (risk ratio = 1.79 [95% confidence interval 1.05, 3.04]) and men (risk ratio = 2.06 [95% confidence interval 1.27, 3.32]).
CONCLUSIONS: High dietary sodium intake suppresses aldosterone, decreases serum calcium, and increases calciuria and the risk for developing kidney stones. Our findings help disentangle the influences of volume from aldosterone on calcium homeostasis and provide support for the recommendation to restrict dietary sodium for kidney stone prevention. © Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  aldosterone; angiotensin; calcium; kidney stone; parathyroid hormone; renin

Mesh:

Substances:

Year:  2020        PMID: 32163150      PMCID: PMC7185954          DOI: 10.1210/clinem/dgaa123

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  46 in total

1.  Hyperparathyroidism can be useful in the identification of primary aldosteronism due to aldosterone-producing adenoma.

Authors:  Gian Paolo Rossi; Fabio Ragazzo; Teresa Maria Seccia; Carmela Maniero; Marlena Barisa; Lorenzo A Calò; Anna Chiara Frigo; Ambrogio Fassina; Achille Cesare Pessina
Journal:  Hypertension       Date:  2012-06-25       Impact factor: 10.190

2.  Primary and Secondary Hyperparathyroidism in Patients with Primary Aldosteronism - Findings From the German Conn's Registry.

Authors:  Evelyn Asbach; Margareta Bekeran; Anna König; Katharina Lang; Gregor Hanslik; Marcus Treitl; Roland Ladurner; Martin Bidlingmaier; Felix Beuschlein; Marcus Quinkler; Martin Reincke
Journal:  Exp Clin Endocrinol Diabetes       Date:  2019-11-07       Impact factor: 2.949

Review 3.  Aldosterone in renal disease.

Authors:  Hassan N Ibrahim; Thomas H Hostetter
Journal:  Curr Opin Nephrol Hypertens       Date:  2003-03       Impact factor: 2.894

4.  Diuretics, calciuria and secondary hyperparathyroidism in the Chronic Renal Insufficiency Cohort.

Authors:  Tamara Isakova; Cheryl A M Anderson; Mary B Leonard; Dawei Xie; Orlando M Gutiérrez; Leigh K Rosen; Jacquie Theurer; Keith Bellovich; Susan P Steigerwalt; Ignatius Tang; Amanda Hyre Anderson; Raymond R Townsend; Jiang He; Harold I Feldman; Myles Wolf
Journal:  Nephrol Dial Transplant       Date:  2011-03-07       Impact factor: 5.992

5.  Mild hyperparathyroidism: a novel surgically correctable feature of primary aldosteronism.

Authors:  Carmela Maniero; Ambrogio Fassina; Teresa M Seccia; Antonio Toniato; Maurizio Iacobone; Mario Plebani; Raffaele De Caro; Lorenzo A Calò; Achille C Pessina; Gian P Rossi
Journal:  J Hypertens       Date:  2012-02       Impact factor: 4.844

6.  Plasma parathyroid hormone and the risk of cardiovascular mortality in the community.

Authors:  Emil Hagström; Per Hellman; Tobias E Larsson; Erik Ingelsson; Lars Berglund; Johan Sundström; Håkan Melhus; Claes Held; Lars Lind; Karl Michaëlsson; Johan Arnlöv
Journal:  Circulation       Date:  2009-05-18       Impact factor: 29.690

7.  Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas.

Authors:  E Rossi; C Sani; F Perazzoli; M C Casoli; A Negro; C Dotti
Journal:  Am J Hypertens       Date:  1995-09       Impact factor: 2.689

Review 8.  Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease.

Authors:  Andreas Tomaschitz; Eberhard Ritz; Burkert Pieske; Astrid Fahrleitner-Pammer; Katharina Kienreich; Jörg H Horina; Christiane Drechsler; Winfried März; Michael Ofner; Thomas R Pieber; Stefan Pilz
Journal:  Cardiovasc Res       Date:  2012-02-13       Impact factor: 10.787

9.  24-h uric acid excretion and the risk of kidney stones.

Authors:  G C Curhan; E N Taylor
Journal:  Kidney Int       Date:  2007-12-05       Impact factor: 10.612

10.  Changes in the perceived epidemiology of primary hyperaldosteronism.

Authors:  Riccardo Maria Fagugli; Chiara Taglioni
Journal:  Int J Hypertens       Date:  2011-08-04       Impact factor: 2.420

View more
  3 in total

1.  Determinants and Outcomes Associated With Urinary Calcium Excretion in Chronic Kidney Disease.

Authors:  Jing Liu; Maria Clarissa Tio; Ashish Verma; Insa M Schmidt; Titilayo O Ilori; Felix Knauf; Finnian R Mc Causland; Sushrut S Waikar
Journal:  J Clin Endocrinol Metab       Date:  2022-01-01       Impact factor: 6.134

2.  Identification of the pivotal role of SPP1 in kidney stone disease based on multiple bioinformatics analysis.

Authors:  Sen-Yuan Hong; Qi-Dong Xia; Jin-Zhou Xu; Chen-Qian Liu; Jian-Xuan Sun; Yang Xun; Shao-Gang Wang
Journal:  BMC Med Genomics       Date:  2022-01-11       Impact factor: 3.063

3.  Reference range for 24-h urine calcium, calcium/creatinine ratio, and correlations with calcium absorption and serum vitamin D metabolites in normal women.

Authors:  L M Smith; J C Gallagher
Journal:  Osteoporos Int       Date:  2020-09-04       Impact factor: 4.507

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.